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The development of new treatments and effective me-
ans to prevent human diseases must be the main goal of 
the health systems of a nation. This objective is easily es-
tablished when the system effectively translates findings 
in biomedical research to clinical practice and uses them 
on decision-makings in health policies. The translational 
research is the basis of this kind of progress constituting a 
continued process that can be divided into two domains. 
The first involves the direct application of discoveries 
coming from research laboratories to the development 
of studies in human beings. These preclinical translatio-
nal investigations are frequently established through the 
use of animal models, tissue culture, human and animals 
cell samples or through experimental systems studying 
biological molecules including DNA, RNA and proteins. 
The second translational domain puts together all the re-
sults from those studies and tries to apply them in clinical 
practice, in an attempt to improve health conditions of 
the population and facilitate the adoption of the best me-
dical practices by the community. Following these reaso-
ning, it has been recognized by the leading scientific jour-
nals and by the main funding agencies that neuroscience is 
the field of the biomedical sciences that grows more rapi-
dly in the developing world. This observation is also valid 
for American Latin countries, in particular Brazil. In these 
lines, the very elegant paper developed recently by Pro-
fessor Ricardo Nitrini demonstrated that more than 40% 
of the Brazilian papers were published in Arquivos de Neu-
ro-Psiquiatria, the official journal of the Brazilian Academy 
of Neurology and that epilepsy was the sub-area with the 
highest scientific production1. Thus, this headline in scien-
tific research in epilepsy is justified by several reasons. 
The epilepsies are the most prevalent neurological di-
sorder and affects around 1% of worldwide population2. 
Furthermore, its high incidence and prevalence produce 
direct repercussion in social and economical aspects3 sin-
ce it increases the economic expenses (medical cares, dru-
gs and hospitalizations). Indirect costs of epilepsy are also 
important such as unemployment due to low production, 
medical license and premature death3,4. Moreover, more 
than 80% of people with epilepsy live in developing coun-
tries5. This fact is due to prenatal deficit assistance, high 
level of premature born, malnutrition, traumas during par-
turition, febrile seizures during childhood and infections 
and parasitism6.  
As a chronic disease, several factors present negative 
impact in the quality of life in people with epilepsy5. A 
number of studies in patients with epilepsy pointed out 
three distinct domains: physical, psychological and social/
vocational domains. The physic domain is related to as-
pects that commit functions such as energy, strength and 
the general health such as loss of energy, fatigue, sleep 
disturbance, number of seizures, seizures gravity and me-
dications side effects. The psychological domain focuses 
emotional and cognition functions as observed in the gre-
at majority of patients with epilepsy, such as depression, 
low self esteem, impairment of memory and sexual dys-
functions. Finally, the social/vocational domain is related 
to restriction in life stile, limitation in sociability, difficul-
ties in leisure time, unemployment, sub-employment, low 
quantity of weddings, difficulties in car drive license and 
to travels5. Unfortunately, all these aspects conduct to 
stigmatization and discrimination of these patients. As ci-
ted by Dr Rajendra Kale, from British Medical Journal “The 
history of epilepsy can be summarized as 4000 years of ig-
norance, superstition and stigma; followed by 100 years of 
knowledge, superstition and stigma”7. Due to these aspects 
and mainly due to etiological heterogeneity of epilepsies, 
it is important to look for new neurobiological mecha-
nisms responsible for the appearance and/or installation 
of this disorder in the central nervous system. In parallel, 
substantial progress related to new diagnostic methods 
and therapeutic approaches should also be developed.
Therefore, the permanent dissemination of the know-
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ledge obtained through this interaction is stimulated by 
international organizations that operate in the epilepsy 
field, in special the International League Against Epilepsy 
(ILAE). In this direction, the Latin American Summer Scho-
ol on Epilepsy (LASSE), an activity of the Educational Pro-
gram of the ILAE with the support of Brazilian League of 
Epilepsy (LBE) has an important role in this scenario. In 
2002, the summer Schools on epilepsy have become re-
ference as a new didactic experience. They have been car-
ried out in the International School of Neurological Scien-
ces, in Venice, Italy, with the participation of researchers 
of basic and clinical areas that act in the field of the epi-
lepsy. As professors and students are in contact during 
two consecutive weeks, this specific School has facilitated 
the integration among them, allowing a better understan-
ding of the new discoveries to the benefit of people with 
epilepsy. Based in this successful experience and with the 
implementation of an Educational Program for the ILAE in 
2006, we also are expanding this type of activity for the 
countries of Latin America with the objective to impro-
ve the knowledge of the basic and clinical neuroscientists 
that act in this area. In brief, the aim of LASSE is to teach 
attendees to acquire basic knowledge in the pathophysio-
logy of epilepsies; understand the clinical aspects of epi-
lepsies and gain from the mutual exchange of information 
between basic scientists and clinicians. Furthermore, it is 
important to note that LASSE is primarily targeted to phy-
sicians pursuing their training or who have recently spe-
cialized in Neurology or other related fields, and research 
scientists from academia and the pharmaceutical industry 
who have an active interest in epileptology. 
Finally, we would like to point out that such summer 
course will continue be performed by us and we have a 
great satisfaction to enunciate that in 2010 the main to-
pic of the IV LASSE will be Epilepsy and Time (for more 
information see: www.lasse.med.br). Overall, we are sure 
that it will be widely divulged with the contribution and 
participation of all researchers and students at all levels 
(scientific initiation, master and PhD) inserted in neuros-
cience field in Latin American.
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